Viking Therapeutics, Inc. (NASDAQ:VKTX) Receives $89.36 Average PT from Analysts
Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) has been given a consensus rating of “Moderate Buy” by the thirteen ratings firms that are covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating, six have assigned a buy rating and […]
16 Feb 10:18 · The Markets Daily